Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Salerno
Clinical trial register · Italy

Clinical Trials in Salerno, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Salerno5 Novartis Pharmaceuticals4 ACADIA Pharmaceuticals Inc.3 Hoffmann-La Roche3 Blueprint Medicines Corporation3
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Salerno

54 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Ancona, Bergamo, Brescia, Milan, Pavia, Perugia, Riccione, Salerno
2026-08-24
Recruiting
VirtualPark_Pediatric
NCT07580365Dystrophinopathy, Muscular Dystrophies, Congenital Myopathies
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato
Not applicable
22
Bosisio Parini, Pisa, Pavia, Salerno
2026-06-30
Not yet open
Liaquat University of Medical & Health Sciences
Not applicable
400
Montevarchi, Rome, Salerno, Urbino
2026-06-22
Recruiting
Hoffmann-La Roche
Phase 2
360
Chieti, Naples, Salerno, Roma, Genoa, Milan, Pavia
2026-03-10
Recruiting
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
800
Roma, Salerno
2025-12-24
Recruiting
AstraZeneca
Observational
335
Salerno, Padova, Teramo, Treviso, Varese, Bari, Bergamo, Bologna
2025-12-20
Recruiting
Hoffmann-La Roche
Phase 3
900
Naples, Salerno, Bologna, Cassino, Rome, Genoa, Brescia, Milan
2025-11-24
Recruiting
Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device
NCT07092436Congenital and Acquired Neuromotor Disorders, Developmental Coordination Disorder (DCD)
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato
Not applicable
54
Bosisio Parini, Calambrone, Salerno, Genova, Milan, Pavia
2025-11-17
Recruiting
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
200
Bologna, Catania, Milan, Padova, Roma, Salerno
2025-09-30
Active, closed
Advanced Robotic Beds for the Early Rehabilitation of Cardiac Surgery Patients
NCT07273669AORTIC VALVE DISEASES, Mitral Valve Failure
University of Salerno
Not applicable
20
Salerno
2025-09-22
Not yet open
GUIDO CAMANNI
Observational
150
Padova, Assisi, Roma, Salerno, Trieste, Varese, Naples
2025-09-15
Recruiting
ACADIA Pharmaceuticals Inc.
Phase 2
180
Naples, Salerno, Brescia, Roma
2025-08-06
Recruiting
AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices
NCT06909682Chronic Heart Failure, Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)
University of Salerno
Observational
205
Salerno
2025-08-01
Recruiting
University of Salerno
Observational
205
Salerno
2025-06-10
Active, closed
Swedish Orphan Biovitrum
Phase 4
252
Catania, Padua, Salerno, Turin
2025-05-21
Recruiting
Pfizer
Phase 2
252
Monserrato, Reggio Emilia, Rozzano, Orbassano, Salerno, Torino, Siena
2025-05-20
Recruiting
Refining mUltiple Artificial intelliGence strateGies for Automatic Pain Assessment Investigations: RUGGI Study
NCT07038434Chronic Pain, Cancer Pain, Neuropathic Pain, Pain Assessment
Valentina Cerrone
Not applicable
200
Salerno
2025-05-06
Active, closed
Novartis Pharmaceuticals
Phase 3
246
Ancona, Caserta, Grosseto, Milan, Rozzano, Perugia, Pordenone, Salerno
2025-04-30
Active, closed
H. Lundbeck A/S
Phase 3
401
Bologna, Milan, Naples, Pisa, Salerno
2024-12-03
Recruiting
Avapritinib Rollover Study
NCT06748001Mastocytosis, Systemic
DrugAvapritinib
Blueprint Medicines Corporation
Phase 4
60
Salerno
2024-11-28
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
100
Bari, Florence, Genova, Milan, Salerno
2024-11-18
Recruiting
IRCCS Fondazione Stella Maris
Not applicable
194
Genova, Bosisio Parini, Milan, Pavia, Calambrone, Salerno
2024-11-04
Recruiting
IRCCS Eugenio Medea
Not applicable
40
Bosisio Parini, Calambrone, Milan, Pavia, Roma, Salerno
2024-10-29
Recruiting
Christian Cipriani
Not applicable
47
Acerenza, Milan, Roma, Salerno, Sant'Angelo dei Lombardi, Tricarico
2024-10-21
Recruiting
Enhancing Palliative Care in ICU
NCT06605079Palliative Care
Charite University, Berlin, Germany
Not applicable
2,040
Perugia, Salerno, Terni
2024-10-10
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Bologna, Catania, Milan, Padova, Roma, Salerno
2024-10-02
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Salerno, Rome, Brescia, Milan, Ponderano (Biella), Roma
2024-09-26
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Brescia, Catania, Chieti, Genova, Monza, Pisa, Roma, Salerno
2024-07-25
Active, closed
Ferrer Internacional S.A.
Phase 2
241
Bologna, Padova, Pisa, Roma, Salerno
2024-07-23
Active, closed
Celldex Therapeutics
Phase 3
976
Genova, Milan, Padova, Rozzano, Salerno, San Donato Milanese, Torino
2024-07-19
Active, closed
Novartis Pharmaceuticals
Phase 2
155
Salerno
2024-07-02
By invitation
ACADIA Pharmaceuticals Inc.
Phase 3
752
Brescia, Salerno, Tricase
2024-04-23
Recruiting
University of Salerno
Observational
1,350
Salerno
2024-03-01
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
DrugACP-204
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Brescia, Cefalù, Isernia, Milan, Roma, Salerno, Torino, Tricase
2023-11-14
Active, closed
Ipsen
Observational
1,057
Foggia, Lecco, Milan, Novara, Salerno, Verona
2023-11-01
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Ancona, Milan, Salerno, Naples
2023-10-27
Recruiting
The ONCOCAMP Study
NCT06270602Oncology
National Cancer Institute, Naples
Observational
15,000
Avellino, Benevento, Caserta, Casavatore, Ercolano, Naples, Salerno
2023-07-14
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Salerno, Rome, Brescia, Milan, Baggiovara, Ponderano (Biella), Florence, Monza
2023-07-11
Recruiting
University of Salerno
Not applicable
30
Salerno
2023-07-03
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Bologna, Milan, Rome, Salerno, Terni, Trento, Tricase
2023-06-27
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Salerno, Rome, Baggiovara, Ponderano (Biella), Florence, Milan, Monza, Pisa
2022-08-23
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ancona, Milan, Salerno, Udine, Naples
2022-08-04
Active, closed
BlueRock Therapeutics
Observational
194
Ancona, Padova, Rome, Salerno
2022-07-29
Active, closed
Centro Cardiologico Monzino
Not applicable
27,520
Scafa, Martano, Reggio Calabria, Benevento, Salerno, Carpi, Pradamano, Pozzilli
2022-06-10
Active, closed
Microvention-Terumo, Inc.
Observational
206
Catania, Messina, Salerno
2022-01-14
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Milan, Florence, Bologna, Catania, Pavia, Salerno, Verona, Vicenza
2021-11-30
Recruiting
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
NCT04996875Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Neoplasm (SM-AHN), Mast Cell Leukemia (MCL), Aggressive Systemic Mastocytosis (ASM)
DrugBezuclastinib
Cogent Biosciences, Inc.
Phase 2
140
Bologna, Florence, Salerno, Verona
2021-11-09
Active, closed
Hoffmann-La Roche
Phase 2
586
Naples, Salerno, Bologna, Rome, Genoa, Brescia, Milan, Pozzilli (IS)
2021-05-05
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsBispecific·Tagrisso·Osimertinib
Merus B.V.
Phase 1/2
194
Roma, Bologna, Brescia, Milan, Orbassano, Salerno, Verona
2021-04-28
Recruiting
Michael J. Fox Foundation for Parkinson's Research
Observational
4,500
Salerno
2020-07-01
Active, closed
Inspiris Resilia Durability Registry
NCT03666741Aortic Valve Stenosis
Institut für Pharmakologie und Präventive Medizin
Observational
400
Florence, Milan, Roma, Salerno
2019-04-26
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Bologna, Milan, Salerno, Verona
2019-04-16
Active, closed
International Bicuspid Aortic Valve Consortium (BAVCon)
NCT01980797Bicuspid Aortic Valve Disease, Thoracic Aortic Disease in Patients With a Bicuspid Aortic Valve
Boston University
Observational
6,464
San Donato Milanese, Naples, Salerno
2013-11
Rows per page Showing 1–54 of 54
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/salerno

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 54 of those studies with a site in Salerno.

How many clinical trials are recruiting in Salerno?

30 of the 54 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 20 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Salerno), 54 studies
PhaseStudiesRecruitingShare
Observational14825.9%
Phase 314625.9%
Not applicable11820.4%
Phase 210518.5%
Phase 2/3223.7%
Phase 4213.7%
Phase 1/2101.9%

Most active sponsors

Lead sponsors with the most studies (Salerno)
Lead sponsorStudiesRecruiting
University of Salerno54
Novartis Pharmaceuticals40
ACADIA Pharmaceuticals Inc.32
Blueprint Medicines Corporation32
Hoffmann-La Roche32
Karuna Therapeutics, Inc., a Bristol Myers Squibb company33
AstraZeneca22
Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato22
Teva Branded Pharmaceutical Products R&D LLC21
BlueRock Therapeutics10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.